Daphne Karydas

MLYS

Daphne Karydas serves as director at Mineralys Therapeutics, Inc. (MLYS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$925.5K

Net Position

Net Seller

$925.5K

Companies Traded

MLYS

Active Period

Nov 2025 – Sep 2026

4 total trades

Most Recent

Sell MLYS

Sep 17, 2026 · $85.7K

Daphne Karydas's Insider Trading at Mineralys Therapeutics, Inc. (MLYS)

Buys

0 · $0.00

Sells

4 · $925.5K

Total Shares Bought

Total Shares Sold

24,000

MLYS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 17, 2026	Sell	3,000	$28.58	$85.7K	6,200
Jun 17, 2026	Sell	3,000	$25.00	$75.0K	6,200
Apr 2, 2026	Sell	3,000	$25.00	$75.0K	6,200
Nov 13, 2025	Sell	15,000	$45.99	$689.8K	4,885